Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01919762 · ClinicalTrials.gov registry record
Detecting Infections Rapidly and Easily for Bacteremia Trial (DIREBT)
A clinical trial, sponsored by T2 Biosystems.
- Completed
- Registry status
- 156
- Enrollment target
NCT01919762: Completed study, sponsored by T2 Biosystems.
NCT01919762 is a clinical trial that has completed, run by T2 Biosystems. The registered enrollment target is 156 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01919762 has completed, sponsored by T2 Biosystems.
- COMPLETED
- Registry status
- 156 participants
- Enrollment target
Study Summary
To assure the uniform collection, handling, storage and transport of patient whole blood specimens and associated information to support validation of the T2 Bacteremia Assay.
Primary Outcome
Number of bacteria positive patients based on concordant, sequential blood culture results and a positive T2 signal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2013-08 |
| Est. Completion | 2015-08 |
What the finished NCT01919762 record still lists
NCT01919762 is an observational study that tracks outcomes without assigning an intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01919762 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01919762 about?
NCT01919762 is a clinical study titled "Detecting Infections Rapidly and Easily for Bacteremia Trial (DIREBT)". To assure the uniform collection, handling, storage and transport of patient whole blood specimens and associated information to support validation of the T2 Bacteremia Assay.
What is the current status of trial NCT01919762?
This trial is currently completed. The enrollment target is 156 participants. The study started on 2013-08. Estimated completion is 2015-08.
Who is sponsoring clinical trial NCT01919762?
This trial is sponsored by T2 Biosystems, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03082755 · 156 participants · Phase 4
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- NCT04047628 · 156 participants · Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- NCT04166877 · 156 participants · Phase 4
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
- NCT04533464 · 156 participants · Phase 2
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia